369 related articles for article (PubMed ID: 17369844)
21. Perturbation of TSG101 protein affects cell cycle progression.
Zhong Q; Chen Y; Jones D; Lee WH
Cancer Res; 1998 Jul; 58(13):2699-702. PubMed ID: 9661875
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
23. Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.
Liu S; Liu W; Jakubczak JL; Erexson GL; Tindall KR; Chan R; Muller WJ; Adhya S; Garges S; Merlino G
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3770-5. PubMed ID: 11867754
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma.
Ma XR; Edmund Sim UH; Pauline B; Patricia L; Rahman J
Trop Biomed; 2008 Apr; 25(1):46-57. PubMed ID: 18600204
[TBL] [Abstract][Full Text] [Related]
25. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
26. A role for the scaffolding adapter GAB2 in breast cancer.
Bentires-Alj M; Gil SG; Chan R; Wang ZC; Wang Y; Imanaka N; Harris LN; Richardson A; Neel BG; Gu H
Nat Med; 2006 Jan; 12(1):114-21. PubMed ID: 16369543
[TBL] [Abstract][Full Text] [Related]
27. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
[TBL] [Abstract][Full Text] [Related]
28. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
29. Protein kinases in mammary gland development and cancer.
Kumar R; Wang RA
Microsc Res Tech; 2002 Oct; 59(1):49-57. PubMed ID: 12242696
[TBL] [Abstract][Full Text] [Related]
30. Mammary gland neoplasia: insights from transgenic mouse models.
Siegel PM; Hardy WR; Muller WJ
Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
[TBL] [Abstract][Full Text] [Related]
31. Loss of Stat5a delays mammary cancer progression in a mouse model.
Ren S; Cai HR; Li M; Furth PA
Oncogene; 2002 Jun; 21(27):4335-9. PubMed ID: 12082622
[TBL] [Abstract][Full Text] [Related]
32. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
33. Absence of TSG101 transcript abnormalities in human cancers.
Trink B; Pai SI; Spunt SL; Raman V; Cairns P; Jen J; Gabrielson E; Sukumar S; Sidransky D
Oncogene; 1998 May; 16(21):2815-8. PubMed ID: 9652749
[TBL] [Abstract][Full Text] [Related]
34. Identification of cellular TSG101 protein in multiple human breast cancer cell lines.
Zhong Q; Chen CF; Chen Y; Chen PL; Lee WH
Cancer Res; 1997 Oct; 57(19):4225-8. PubMed ID: 9331081
[TBL] [Abstract][Full Text] [Related]
35. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
Guo W; Pylayeva Y; Pepe A; Yoshioka T; Muller WJ; Inghirami G; Giancotti FG
Cell; 2006 Aug; 126(3):489-502. PubMed ID: 16901783
[TBL] [Abstract][Full Text] [Related]
36. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
[TBL] [Abstract][Full Text] [Related]
37. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
38. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal.
Diehl KM; Grewal N; Ethier SP; Woods-Ignatoski KM
J Surg Res; 2007 Sep; 142(1):162-9. PubMed ID: 17612563
[TBL] [Abstract][Full Text] [Related]
39. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
40. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
